6 recruiting. 6 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Recruiting 6 |
| Phase 3 | 1 | Recruiting 1 |
Follow Ulcer: new trials by email Literature Review of Ulcer trials Research Report on Ulcer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis Etrasimod - Colitis, Ulcerative | Phase 2 | Recruiting | Pfizer | 24 | 2026-05-28 | 2026-10-26 |
| Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC) ATH-063, Placebo - Ulcerative Colitis, Inflammatory Bowel Diseases | Phase 2 | Recruiting | Athos Therapeutics Inc | 120 | 2026-04-30 | 2026-09-21 |
| Study of a Copaiba-Based Mouthwash Combined With Low-Level Laser Therapy in the Prevention of Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation Copaíba, Placebo - Oral Mucositis, Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy | Phase 2 | Recruiting | Instituto Nacional de Cancer, Brazil | 76 | 2026-03-29 | 2026-09-09 |
| Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma propranolol - Infantile Hemangioma | Phase 2 / Phase 3 | Recruiting | West China Hospital | 32 | 2025-01-01 | 2026-09-21 |
| Telacebec (T) Treatment in Adults With Buruli Ulcer (BU). (TREAT BU) Telacebec - Buruli Ulcer | Phase 2 | Recruiting | Barwon Health | 200 | 2024-07-09 | 2026-06-30 |
| Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients. N-Acetyl-Cysteine with Institutional standard care, Institutional standard care - Oral Mucositis (Ulcerative) Due to Radiation | Phase 2 | Recruiting | Mansoura University | 50 | 2024-04-04 | 2025-01-15 |
Colitis (2) · Colitis, Ulcerative (2) · Stomatitis (2) · Autoimmune Diseases (1) · Buruli Ulcer (1) · Hemangioma, Capillary (1) · Inflammatory Bowel Diseases (1)
Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Colonic Diseases (2) · Digestive System Diseases (2) · Gastroenteritis (2) · Gastrointestinal Diseases (2) · Intestinal Diseases (2) · Mouth Diseases (2) · Stomatognathic Diseases (2) · Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Gram-Positive Bacterial Infections (1) · Hemangioma (1) · Immune System Diseases (1)
Acetylcysteine (1) · Propranolol (1) · etrasimod (1) · telacebec (1)
Athos Therapeutics Inc (1) · Barwon Health (1) · Instituto Nacional de Cancer, Brazil (1) · Mansoura University (1) · Pfizer (1) · West China Hospital (1)
Australia (2) · United States (2) · Brazil (1) · Canada (1) · China (1) · Egypt (1) · France (1) · Germany (1) · Israel (1) · Italy (1) · Japan (1) · Poland (1) · United Kingdom (1)
Daniel O'Brien, MD (1) · David T. Rubin, MD (1) · Fatma Gharib Khirallah, Associate Professor (1) · Mohamed Awad Ebrahim, Professor (1) · Noha Mansour, phD (1) · Rasha Mohamed Abd-Ellatif, Professor (1)
2025 (1)